|
|
The U.S.-China Workshop on Developing Common Standards
for Biorepositories and Biospecimen Research
|
This international workshop is co-sponsored by the National Cancer Institute (NCI)'s Office of Biorepositories and Biospecimen Research (OBBR) and the National Foundation for Cancer Research (NFCR), and co-hosted by Tianjin Medical University Cancer Institute and Hospital (TMUCIH) and NFCR in Tianjin on October 19, 2011. This Workshop is designed to advance cancer research by raising awareness about the importance of developing and implementing common standards for biorepositories in the U.S. and China and of the need to initiate a process to identify and agree upon standards that can be implemented in both countries.
NCI has long recognized the need to standardize and optimize biospecimen and data collections for cancer research and has made a significant effort to establish evidence-based best practices in the field. This initiative culminated in the "NCI Best Practices for Biospecimen Resources" (NCI Best Practices). The NCI Best Practices were originally published in 2007 and an updated version is to be released in 2011.
In 2004, NFCR and Tianjin Medical University Cancer Institute and Hospital (TMUCIH) established a Joint Tissue Bank (JTB) to collect and store fresh frozen tumor tissue and blood samples for use in cutting-edge cancer research. By 2007, the JTB had evolved into a larger project - serving as a research collaboration platform in China -- the Tissue Bank Consortium in Asia (TBCA) -- with multiple cancer tissue banks from major hospitals in China joining the TBCA as member banks. Today, TBCA is becoming a China-focused biorepository network in Asia that operates according to international standards.
This Joint Workshop will further NCI's mission through dissemination and exchange of scientific knowledge about standards for biorepositories nationally and internationally. It will also support and promote research collaborations among scientific communities in China and the United States. It is the NCI's and NFCR's belief that international cooperation and the adoption of common standards and practices in collecting, storing, and monitoring the use of high quality tumor and blood samples and related clinical data can help advance translational research and will encourage the development of new diagnostic tools and therapies for cancer.
8:30 - 8:45 am Opening Remarks
Webster Cavenee, Ph.D.
Professor and Director, Ludwig Institute for Cancer Research, San Diego
Chair, Tissue Bank Consortium in Asia
Franklin Salisbury Jr., J.D.
President, National Foundation for Cancer Research
8:45 - 9:20 am Welcome Remarks
Xishan Hao, M.D.
President, Tianjin Medical University and Tianjin Cancer Institute and Hospital
9:20 - 9:25 am Introduction of Workshop Goal
Benjamin Fombonne
OBBR, National Cancer Institute (NCI)
9:25 - 10:10 am The Role of Biospecimens in Translational Research and Molecularly Informed Medicine
Carolyn Compton, M.D., Ph.D.
Director, OBBR, National Cancer Institute (NCI)
10:10 - 10:25 am Coffee Break and Networking
10:25 - 12:45 pm BIOBANKING IN CHINA
Session Chair: Xishan Hao, M.D.
President, Tianjin Medical University and Tianjin Cancer Institute and Hospital
10:25 - 10:45 am Building up a High Quality Biorepository at Tianjin Cancer Institute and Hospital - Part of a National Platform-Building Program Funded by the Ministry of Science and Technology of China
Xishan Hao, M.D.
President, Tianjin Medical University and Tianjin Cancer Institute and Hospital
10:45 - 11:05 am Case Study: Navigating Towards Successful International Collaborations with the Biospecimens from China
Wei Zhang, Ph.D.
Professor and Director, Cancer Genomics Core Laboratory
M.D. Anderson Cancer Center
11:05 -11:25 am The Legal and Regulatory Issues on Biospecimen Use in China
Guoping Zhao, Ph.D.
Professor and Director, National Engineering Center for BioChips
11:25 - 11:45 am TBD
Qimin Zhan, Ph.D
Professor and Vice President, Chinese Acadamy of Medical Sciences
& Peking Union Medical College
11:45 - 12:05pm Developing a Standardized and Well-annotated Human Liver Cancer Biorepository: The National Liver Cancer Tissue Bank Project of China
Weiping Zhou, M.D.
Director, The 3rd Department of Hepatic Surgery
Eastern Hepatobiliary Surgery Hospital, Shanghai
12:05 - 2:00 pm Lunch Break and Networking
2:00 - 3:20 pm INFORMATICS
Session Chair: Carolyn Compton, M.D., Ph.D.
Director, OBBR, National Cancer Institute (NCI)
2:00 - 2:40pm Implementation of Robust Information Systems for Management of Biospecimens and Ensuring their Interoperability with Clinical and Research Data Systems
Dr. Ian Fore, D.Phil.
Director, Biorepository and Pathology Informatics
Center for Bioinformatics and Information Technology, NCI
2:40 - 3:20 pm Identifying Specimens across Systems and Use of Standard Terminologies for Specimen Data
Lei Liu, Ph.D.
Deputy Director, Shanghai Center for Bioinformation Technology
3:20 - 3:35 pm Coffee Break and Networking
3:35 - 5:35 pm Technical and Operational Practices and Considerations
Session Chair: Wei Zhang, Ph.D.
Professor and Director, Cancer Genomics Core Laboratory
M.D. Anderson Cancer Center
3:35 - 4:15 pm The Need for Clear Standard Operating Procedures: How Pre & Post-Acquisition Variables Affect Sample Quality and Integrity
Carolyn Compton, M.D., Ph.D.
Director, OBBR, National Cancer Institute (NCI)
4:15 - 4:55 pm Business of Biobanking: Economics and Sustainability - Planning, Legacy Organizational Structure, Cost Recovery...
Chon Boon Eng, Ph.D.
Head of Tissue Repository and Hospital Based Cancer Registry
National University of Singapore-National University Hospital
4:55 - 5:35 pm Asian Network of Pediatric Oncology: Structure, Operational Model and Sustainability
Akira Nakagawara, M.D., Ph.D.
President, Chiba Cancer Center, Chiba, Japan
5:35 - 5:45 pm Closing Remarks
Sujuan Ba, Ph.D.
Chief Operating Officer, National Foundation for Cancer Research
Co-Chair, Tissue Bank Consortium in Asia
6:30 - 8:30 pm Farewell Dinner Reception
About the National Foundation for Cancer Research
NFCR was founded in 1973 to support cancer research and public education relating to prevention, earlier diagnosis, better treatments and ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. NFCR is committed to Research for a Cure - cures for all types of cancer.
To learn more about NFCR, visit: www.NFCR.org.
About the National Cancer Institute
The NCI mission is to conduct and support research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
To learn more about NCI, visit: www.cancer.gov.
About the Office of Biorepositories and Biospecimen Research
The mission of OBBR is to guide, coordinate, and develop the Institute's biospecimen resources and capabilities and ensure that human biospecimens available for cancer research are of the highest quality. This will be accomplished through the development of a common biorepository infrastructure that promotes resource sharing and team science, in order to facilitate multi-institutional, high throughput genomic and proteomic studies.
To learn more about OBBR, visit: www.biospecimens.cancer.gov.
|
